CCR7 Antibody
(Synonyms: CCR7_HUMAN; BLR 2; BLR2; C C chemokine receptor type 7; C C CKR 7; CC chemokine receptor 7; CC chemokine receptor type 7; CC CKR 7; CCCKR7; CCR 7; CD 197; CD197; CD197 antigen; CDW197; Chemokine C C motif receptor 7; Chemokine C C receptor 7; Chemokine receptor 7-like protein; EBI 1; EBI1; Ebi1h; EBV Induced G Protein Coupled Receptor 1; Epstein Barr virus induced G protein coupled receptor; Epstein Barr virus induced gene 1; EVI 1; EVI1; Lymphocyte Specific G Protein Coupled Peptide Receptor; MGC108519; MIP 3 beta receptor; MIP3 Beta Receptor.)Based on 1 publication(s) in Google Scholar
CCR7 Antibody is a Rabbit-derived and non-conjugated IgG polyclonal antibody, targeting to CCR7.
-
Host:
Rabbit
-
Isotype:
IgG
-
Application:
WB, IHC-P, ICC/IF, ELISA
-
Reactivity :
Human, Mouse, Rat
-
Formulation:
Supplied in 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
-
Conjugation:
Non-conjugated
Publications Citing Use of MedChemExpress (MCE) CCR7 Antibody
More
Applications
| Application |
WB
WB: Western Blot
|
ELISA
ELISA: Enzyme Linked Immunosorbent Assay
|
IHC-P
IHC-P: Immunohistochemistry-Paraffin
|
ICC/IF
ICC/IF: Immunocytochemistry/
Immunofluorescence |
ICC/IF
ICC/IF: Immunocytochemistry/
Immunofluorescence |
|---|---|---|---|---|---|
| Dilution Ratio | 1:500-2000 | 1:5000-10000 | 1:100-500 | 1:100 | 1:100-500 |
Product Details
CCR7 Antibody is a Rabbit-derived and non-conjugated IgG polyclonal antibody, targeting to CCR7.
-
Host Rabbit
-
Clonality Polyclonal
-
Species ReactivityHuman, Mouse, Rat Predicted Reactivity: DogNote: The predicted reactivity is for reference only and should not be considered a guarantee of product performance.
-
Observed Molecular WeightObserved band size: 42 kDaNote: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.
-
Calculated Molecular Weight Predicted band size: 42 kDa
Entrez Gene: 1236 Human ; 12775 Mouse ; 287673 Rat
SwissProt: P32248 Human ; P47774 Mouse ;
OMIM: 600242 Human
KLH conjugated synthetic peptide derived from human CCR7: 25-59/379
Endogenous
affinity purified
Non-conjugated
Unmodified
IgG
Product Properties
-
Appearance
Solution
-
Formulation
Supplied in 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
-
Concentration
Batch-dependent, Please check the COA for the concentration of each lot. Check Lot Concentration
-
Storage & Stability
Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.
-
Shipping
Shipping with blue ice.
Publications (1)
-
Journal Impact Factor
-
Most Recent
Verification Images
-
Western blot analysis of extracts from M-Spleen (lane 1) and M-lymph (lane 2) and M-lung (lane 3) using CCR7 antibody. Proteins were transferred to a PVDF membrane and blocked with 5% nonfat powdered milk in PBST for 2 hour at room temperature. The primary antibody (1/1000) and Loading control antibody (GAPDH, 1/3000) was diluted with 5% nonfat powdered milk in PBST at 4°C overnight. Goat Anti-Rabbit IgG-HRP Secondary Antibody (1/8,000) was incubated for 45min at room temperature.
Background
-
Function
CCR7 is a CC chemokine receptor that organizes primary immune responses by positioning T cells and dendritic cells within secondary lymphoid organs[1]. Mechanistically, CCL19 and CCL21 activate CCR7 to guide lymph-node homing, dendritic-cell migration, and T-cell priming[2][3]. In disease models, CCR7 supports melanoma lymph-node metastasis and CNS infiltration in T-cell leukemia, showing its relevance to tumor dissemination research[4][5]. Compared with related chemokine-receptor axes, CCR7 is defined by its paired ligands CCL19/CCL21 and their biased signaling, because CCL19 strongly promotes arrestin-mediated receptor endocytosis whereas CCL21 does not[6][7]. For experimental applications, anti-CCR7 antibodies reduced mantle-cell lymphoma growth and dissemination in xenograft models, supporting CCR7 blockade as a research tool for migration-dependent malignancy models[8].
-
Subcellular Localization
Cell membrane; Multi-pass membrane protein
-
SwissProt ID
-
Synonyms
CCR7_HUMAN; BLR 2; BLR2; C C chemokine receptor type 7; C C CKR 7; CC chemokine receptor 7; CC chemokine receptor type 7; CC CKR 7; CCCKR7; CCR 7; CD 197; CD197; CD197 antigen; CDW197; Chemokine C C motif receptor 7; Chemokine C C receptor 7; Chemokine receptor 7-like protein; EBI 1; EBI1; Ebi1h; EBV Induced G Protein Coupled Receptor 1; Epstein Barr virus induced G protein coupled receptor; Epstein Barr virus induced gene 1; EVI 1; EVI1; Lymphocyte Specific G Protein Coupled Peptide Receptor; MGC108519; MIP 3 beta receptor; MIP3 Beta Receptor.
Documentation
-
Data Sheet (261 KB)
-
SDS (254 KB)
- English - EN (254 KB)
- Français - FR (254 KB)
- Deutsch - DE (254 KB)
- Norwegian - NO (254 KB)
- Español - ES (254 KB)
- Swedish - SV (254 KB)
- Italian - IT (254 KB)
- Korean - KR (254 KB)
- Portuguese - PT (254 KB)
-
User Guide for Antibodies (1077 KB)
[1]. Förster R, et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell. 1999 Oct 1;99(1):23-33. [Content Brief]
[2]. Förster R, et al. CCR7 and its ligands: balancing immunity and tolerance. Nat Rev Immunol. 2008 May;8(5):362-71. [Content Brief]
[3]. Ohl L, et al. CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity. 2004 Aug;21(2):279-88. [Content Brief]
[4]. Wiley HE, et al. Expression of CC chemokine receptor-7 and regional lymph node metastasis of B16 murine melanoma. J Natl Cancer Inst. 2001 Nov 7;93(21):1638-43. [Content Brief]
[5]. Buonamici S, et al. CCR7 signalling as an essential regulator of CNS infiltration in T-cell leukaemia. Nature. 2009 Jun 18;459(7249):1000-4. [Content Brief]
[6]. Hauser MA, et al. Common and biased signaling pathways of the chemokine receptor CCR7 elicited by its ligands CCL19 and CCL21 in leukocytes. J Leukoc Biol. 2016 Jun;99(6):869-82. [Content Brief]
[7]. Byers MA, et al. Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21. J Immunol. 2008 Oct 1;181(7):4723-32. [Content Brief]
[8]. Somovilla-Crespo B, et al. Anti-CCR7 therapy exerts a potent anti-tumor activity in a xenograft model of human mantle cell lymphoma. J Hematol Oncol. 2013 Dec 4;6:89. [Content Brief]